See you there.
China sales are exploding too.
1, Amazing data from animal studies halting and even reversing AD.
2. Human testing results so far,
3. Michael J. Fox Foundation funding a study in Parkinson
4. Dr. Misslings experience in Biotech.
5. Market valuation as compared to other AD drug companies such as AXON
6. Misslings desire to partner and not go it alone.
7. FDA guidance
8. Invitation of meeting with Congress last month
9. Not a one trick pony. many other CNS diseases being worked on
10. results in AD and Epilepsy seem to be far better than SOC ( standard of care)
Thanks for the Linda L. comments here. They were very comforting.
On November 18, 2015, Anavex announced that it is moving forward with the development program for ANAVEX 2-73 based on formal interaction and guidance from the FDA, which confirmed the Company’s strategy to advance ANAVEX 2-73 for the treatment of Alzheimer’s disease in a larger double-blinded, randomized, placebo-controlled Phase 2/3 trial.
See web page, Imo wouldn't present if data wasn't great.
Adding to strong companies like AVXL on these down days.
Regultors allowing shorts to manipulate imo. When do they look out for mom and pop against this short barrage?
Wrong they only used the word formal on 12-29 after SEC so they would be even more apt not to hype..U are so short !
So i will buy today.
AF tweets. These guys must be afarid of recent SEC probes into short sellers, manipulation, and connections. Martin. Steve Cohan..whio is next?